Skip to main content
. 2021 Mar 4;11:5148. doi: 10.1038/s41598-021-84561-7

Figure 3.

Figure 3

The discriminative efficacy (ROC analysis) of lesion assessments, measured by lobar lesion assessment (A), segmental lesion assessment (B), opacity-weighted lesion assessment (C), and lesion volume quantification (D), between severe type and common type patients with COVID-19.